Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04328181
Other study ID # 69HCL19_0486
Secondary ID ID-RCB
Status Recruiting
Phase N/A
First received
Last updated
Start date January 29, 2021
Est. completion date January 29, 2026

Study information

Verified date April 2024
Source Hospices Civils de Lyon
Contact Philippe DOUEK, Pr
Phone 04 72 07 18 83
Email douek@creatis.insa-lyon.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This pilot study wants to determine to which extent SPCCT allows obtaining images with improved quality and diagnostic confidence when compared to standard Dual Energy CT (DECT), both with and without contrast agent injection. Depending on the anatomical structures/organs to be visualized during CT examinations, different scanning protocols are performed with quite variable ionizing radiation doses. Therefore, in order to obtain the most extensive and representative results of the improvement in image quality between SPCCT and DECT that will be performed CT imaging on several body regions and structures, including diabetic foot, diabetic calcium coronary scoring, adrenal glands, coronary arteries, lung parenchyma, kidney stones, inner ear, brain and joints, earl/temporal bone, colorectal carcinosis.


Recruitment information / eligibility

Status Recruiting
Enrollment 339
Est. completion date January 29, 2026
Est. primary completion date January 29, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients presenting following one of following medical conditions: 1. Asymptomatic type 1 or 2 diabetes as regard to cardiovascular risks 2. Diabetic foot ulcer 3. Adrenal glands lesions: Adrenal incidentaloma or hyperaldosteronism or macroadenoma 4. Urinary stone(s) 5. Known Coronary artery disease: Stent imaging or control of calcified plaques 6. Diffuse Interstitial Lung Diseases: Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis, Ground Glass Opacification, Chronic Thromboembolic Pulmonary Hypertension 7. Conductive hearing loss 8. Brain stroke (late or post thrombectomy) 9. Intracranial arteriovenous malformation treated with coils or Onyx 10. Joints diseases in haemophilia 11. Ear/temporal bone 12. Colorectal carcinosis 13. Dissection aortique de type A opérée ou de type B non opérée, hématome intramural - Patient has accepted to participate to the study and has signed the written consent; - Pre-menopausal women only: Negative urinary pregnancy test on the day of imaging before the administration of study drug; - Patient is affiliated to the French social security Exclusion Criteria: - Contraindication to the use of iodine containing contrast media (including subjects with suspicion for/or known to have NSF) (if injection); - History of severe allergic or anaphylactic reaction to any allergen including drugs and contrast agents (as judged by the investigator, taking into account the intensity of the event); - History of delayed major or delayed cutaneous reaction to Iomeron injection - Estimated Glomerular Filtration Rate (eGFR) value < 30 mL/min/1.73 m2 derived from a serum creatinine result within 1 month before the imaging for examinations with contrast agent. - Any subject on hemodialysis or peritoneal dialysis; - Suspected clinical instability or unpredictability of the clinical course during the study period (e.g. due to previous surgery); - Pregnant or nursing (including pumping for storage and feeding); - Patient under guardianship, curatorship or safeguard of justice.

Study Design


Related Conditions & MeSH terms

  • Adrenal Incidentaloma
  • Adrenocortical Adenoma
  • Arteriovenous Malformations
  • Brain Stroke
  • Coronary Artery Disease
  • Diabetes
  • Diabetic Foot
  • Diabetic Foot Ulcer
  • Ear Diseases
  • Foot Ulcer
  • Hyperaldosteronism
  • Inner Ear Disease
  • Interstitial Lung Disease
  • Intracranial Arteriovenous Malformations
  • Joint Diseases
  • Kidney Calculi
  • Kidney Stone
  • Labyrinth Diseases
  • Labyrinthitis
  • Lung Diseases
  • Lung Diseases, Interstitial
  • Macroadenoma
  • Parenchymatous; Pneumonia

Intervention

Device:
Spectral Photon Counting Computed Tomography (SPCCT)
For the dual-layer spectral CT scanner (IQon®, Philips, Amsterdam, The Netherlands), the following parameters will be used for the acquisition: Tube potential 120 kVp; Tube current time product of 150 mAs; Gantry revolution time 0.33 s; Automatic exposure control (angular and longitudinal) combined xyz-axis; Beam collimation geometry 64 x 0.625 mm - scan field-of-view - 22 cm;
DECT (Dual Energy CT)
The SPCCT scanner is a prototype spectral photon-counting computed tomography system derived from a modified clinical CT system with a field-of-view (FOV) of 168 mm in-plane, and a z-coverage of 20 mm. It is equipped with energy-sensitive photon-counting detectors relying on the direct conversion high band gap semiconductor of cadmium zinc telluride (CZT). The electronics comprises 5 rate counters with 5 different configurable energy thresholds. The SPCCT scanner has the following parameters: Base platform : iCT scanner Tube Voltage (kVp) : 120, capability for imaging at 80 and 100 kVp Tube current (mA) : 10 - 300 Spatial Resolution : > 30 lp/cm, = 250 µm Z-coverage isocenter (mm) : 20 mm FOV (mm) : 500 Minimum rotation time : 0.33 s/rotation Acquisition modes : Axial, Helical, Step & Shoot

Locations

Country Name City State
France Hôpital Cardiologique Louis Pradel - Hospices Civils de Lyon Bron Avenue Doyen Lépine

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary quality of the images A single four-point scale will be used (1: unacceptable, 2: usable under limited conditions, 3: probably acceptable, 4: fully acceptable) based on the European guidelines on quality criteria for computed tomography Day 8
Secondary Diagnostic confidence graded The diagnostic confidence grade will be calculated on a four-point scale (1: insufficient, 2: poor, 3: average, 4: good). Day 8
Secondary Subjective image quality graded It will be calculated on a five-point scale (1: poor, 2: fair, 3: average, 4: good, 5: excellent) for each following criterion: noise, artifacts and sharpness. Day 8
Secondary CT Dose Index volumic (CTDIvol) To determine the radiation dose delivered to the patients during the DECT and SPCCT imaging procedures.
The CTDI is an estimation of the dose delivered to the organs for each acquired section that is based on acquisition parameters of a water phantom with a 32 cm diameter. The value is expressed in milligray (mGy).
Day 8
Secondary Dose Length Product (DLP) To determine the radiation dose delivered to the patients during the DECT and SPCCT imaging procedures.
The DLP is obtained as follows: CTDI * length of body explored = value in mGy.cm.
Day 8
Secondary Equivalent dose (mSv) To determine the radiation dose delivered to the patients during the DECT and SPCCT imaging procedures.
The equivalent dose is obtained by multiplying the DLP to the specific organ conversion factor.
Day 8
Secondary Quantitatively image quality : Noise The noise by selecting regions of interest (ROI) will calculated. Day 8
Secondary Quantitatively image quality : Density The density (HU) by selecting regions of interest (ROI) will calculated. Day 8
Secondary Quantitatively image quality : contrast-to-noise ratio The contrast-to-noise ratio (CNR) by selecting regions of interest (ROI) will calculated. Day 8
Secondary Depiction of anatomical structures of interest Depiction of anatomical structures of interest will be graded on a four-point scale (1: visualization just possible, 2: unclear borders but different structures already visible, 3: very good visualization, well-defined anatomy, 4: perfect delineation of anatomy). Day 8
Secondary Radiation dose An average radiation dose delivered to the patients for each clinical application will be calculated. Day 8
Secondary Statistical comparison between SPCCT and DECT Statistical comparison between SPCCT and DECT will be performed over all images and anatomical structures globally and also for each clinical application of interest. Day 8
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions N/A